US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
GOOGL
$279.84
▼-1.40%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
GOOGL
$279.84
▼-1.40%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Pharmather
Recent news which mentions Pharmather
PharmaTher Provides Business Highlights And Releases Audited Annual Financials
September 29, 2022
Tickers
PHRRF
Tags
Penny Stocks
Psychedelics
Earnings
From
Benzinga
PharmaTher Granted Orphan Drug Designation for Life-Saving Seizure Medicine
February 02, 2022
Tags
psychedelics
Biotech
Market News
From
Benzinga
Psychedelic Medicine Co. PharmaTher Provides Update On Pipeline And Milestones For 2022
January 25, 2022
Tickers
PHRRF
Tags
contributors
Pharmather
Ketamine
From
Benzinga
FDA Approves PharmaTher's Phase 2 Trial For Ketamine ALS Treatment
January 12, 2022
Tickers
ALS
PHRRF
Tags
News
PHRRF
Benzinga
From
Benzinga